Lower risk of hypoglycaemia and greater odds for weight loss with initiation of insulin detemir compared with insulin glargine in Turkish patients with type 2 diabetes mellitus: local results of a multinational observational study

Once-daily initiation of basal insulin as add-on to metformin: a 26-week, randomized, treat-to-target trial comparing insulin detemir with insulin glargine in patients with type 2 diabetes

(2013) L. Meneghini et al.   DIABETES OBESITY & METABOLISM

Effect of Baseline Glycosylated Hemoglobin A1c on Glycemic Control and Diabetes Management Following Initiation of Once-Daily Insulin Detemir in Real-Life Clinical Practice

(2013) Salvatore Caputo et al.   Endocrine Practice

Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults

(2013) Ilhan Satman et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Standards of Medical Care in Diabetes--2013

(2012)   DIABETES CARE

Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

(2012) S. E. Inzucchi et al.   DIABETES CARE

The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries

(2012) K. Khunti et al.   DIABETES OBESITY & METABOLISM

Study of Once Daily Levemir (SOLVE™): insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice

(2012) K. Khunti et al.   DIABETES OBESITY & METABOLISM

Insulin analogues dosing and costs - comparing real-life daily doses of insulin detemir and insulin glargine in type 2 diabetes patients

(2012) Marie Jakobsen et al.   BMC Endocrine Disorders

First insulinization with basal insulin in patients with Type 2 diabetes in a real-world setting in Asia

(2011) Shih-Tzer TSAI et al.   Journal of Diabetes

A 24-Week, Randomized, Treat-to-Target Trial Comparing Initiation of Insulin Glargine Once-Daily With Insulin Detemir Twice-Daily in Patients With Type 2 Diabetes Inadequately Controlled on Oral Glucose-Lowering Drugs

(2010) S. G. Swinnen et al.   DIABETES CARE

Type 2 Diabetes Care and Insulin Intensification

(2010) Robert M. Cuddihy et al.   DIABETES EDUCATOR

Comparison of Insulin Detemir and Insulin Glargine on Glycemic Variability in Patients with Type 1 and Type 2 Diabetes

(2010) A. Tone et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database study

(2010) J. Gordon et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Once-daily insulin detemir in a cohort of insulin-naïve patients with type 2 diabetes: a sub-analysis from the PREDICTIVE study

(2009) L. F. Meneghini et al.   CURRENT MEDICAL RESEARCH AND OPINION

Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes

(2009) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE

A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes

(2008) Priscilla Hollander et al.   CLINICAL THERAPEUTICS

Long-acting insulin analogues versus NPH human insulin in type 2 diabetes

(2008) Matteo Monami et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Changing the glucose cut-off values that define hypoglycaemia has a major effect on reported frequencies of hypoglycaemia

(2008) S. G. H. A. Swinnen et al.   DIABETOLOGIA

A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes

(2008) J. Rosenstock et al.   DIABETOLOGIA

Insulin detemir improves glycaemic control without weight gain in insulin-naïve patients with type 2 diabetes: subgroup analysis from the PREDICTIVETM study

(2008) A. Dornhorst et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE